Targeting the transferrin receptor in breast cancer: nanotechnology-based drug delivery strategies
- Published on 03/03/2026
- Reading time: 1 min.
Zhendi Song a , Chunlei Song b , Xiaoli Yi c , Yashu Shao d & Yan Zhang c,*
a Department of Breast Surgery, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, China
b Department of Emergency Surgery, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, China
c Department of Oncology, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, China
d Office of Undergraduate Liberal Education, Duke Kunshan University, Kunshan, China
CONTACT Yan Zhang mailto:yan.zhang.qd@outlook.com; mailto:nmedresearch@gmail.com Department of Oncology, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao 266000, China
To continue reading this article in Full-Text...
Peer-Reviewed Journals A-Z
Search | Advanced search
Get the latest news in Oncology
Receive our newsletter to stay up to date with the latest news in Oncology
